华绿生物
(300970)
| 流通市值：12.27亿 | | | 总市值：15.90亿 |
| 流通股本：9272.94万 | | | 总股本：1.20亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 373,324,620.9 | 361,137,972.25 | 336,854,042.32 | 316,089,705.13 |
| 应收票据及应收账款 | 20,004,757.55 | 16,696,728.6 | 19,492,553.01 | 16,468,266.94 |
| 应收账款 | 20,004,757.55 | 16,696,728.6 | 19,492,553.01 | 16,468,266.94 |
| 预付款项 | 3,077,614.72 | 2,607,922.27 | 6,416,118.78 | 9,046,762.52 |
| 其他应收款合计 | 2,117,972.94 | 1,891,538.89 | 3,528,853.44 | 3,099,156.44 |
| 其中:应收利息 | - | - | 1,229,569.93 | 1,063,213.75 |
| 存货 | 202,625,108.71 | 196,073,298.03 | 193,503,698.53 | 181,385,415.8 |
| 其他流动资产 | 1,013,239.89 | 1,568,650.75 | 1,958,047.77 | 867,166.4 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 602,163,314.71 | 579,976,110.79 | 561,753,313.85 | 526,956,473.23 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 321,064.62 | 330,335.6 | 393,808.26 | 396,183.84 |
| 固定资产 | 1,357,708,638.48 | 1,364,751,902.73 | 1,201,875,559.45 | 1,173,626,423.59 |
| 在建工程 | 92,433,983.74 | 95,298,461.79 | 206,164,118.02 | 200,377,368.23 |
| 使用权资产 | 174,011,332.63 | 182,377,686.85 | 212,660,548.87 | 80,269,267.7 |
| 无形资产 | 57,554,164.54 | 58,017,578.35 | 57,248,019.48 | 57,681,114.21 |
| 长期待摊费用 | 24,999.86 | 37,499.87 | 69,144.45 | 134,458.59 |
| 其他非流动资产 | 23,109,348.28 | 24,725,608.75 | 63,299,694.99 | 52,397,745.61 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,705,163,532.15 | 1,725,539,073.94 | 1,741,710,893.52 | 1,564,882,561.77 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,307,326,846.86 | 2,305,515,184.73 | 2,303,464,207.37 | 2,091,839,035 |
| 流动负债: | | | | |
| 短期借款 | - | - | 20,011,361.14 | 20,013,916.67 |
| 应付票据及应付账款 | 73,360,021.86 | 73,310,932.31 | 71,530,494.96 | 80,256,159.68 |
| 应付账款 | 73,360,021.86 | 73,310,932.31 | 71,530,494.96 | 80,256,159.68 |
| 预收款项 | 2,444,501.75 | 3,431,185.05 | - | - |
| 合同负债 | - | 3,431,185.05 | 2,683,045.31 | 3,041,540.99 |
| 应付职工薪酬 | 27,662,749.89 | 28,407,763.04 | 25,421,450.29 | 24,652,427.54 |
| 应交税费 | 216,298.16 | 345,335.6 | 239,697.46 | 243,399.72 |
| 其他应付款合计 | 57,731,350.74 | 68,246,260.42 | 53,175,080.2 | 59,030,531.9 |
| 一年内到期的非流动负债 | 48,752,845.35 | 48,845,980.66 | 5,856,355.63 | 14,235,679.15 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 210,167,767.75 | 222,587,457.08 | 178,917,484.99 | 201,473,655.65 |
| 非流动负债: | | | | |
| 长期借款 | 313,092,408.2 | 302,943,926.09 | 335,672,047.53 | 260,754,507.1 |
| 租赁负债 | 216,039,035.64 | 214,407,954.65 | - | 100,672,446.28 |
| 长期应付款 | - | - | 238,259,836.34 | - |
| 预计负债 | 269,017 | 330,545.5 | - | - |
| 递延收益 | 43,611,263.39 | 45,853,289.44 | - | 43,417,868.98 |
| 其他非流动负债 | - | - | 48,193,912.54 | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 573,011,724.23 | 563,535,715.68 | 622,125,796.41 | 404,844,822.36 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 783,179,491.98 | 786,123,172.76 | 801,043,281.4 | 606,318,478.01 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 120,202,400 | 120,202,400 | 117,888,600 | 117,888,600 |
| 资本公积 | 918,546,445.65 | 915,755,388.11 | 890,709,499.86 | 885,326,997.6 |
| 减:库存股 | 30,012,706.01 | 30,012,706.01 | 30,012,706.01 | 30,012,706.01 |
| 盈余公积 | 48,367,103 | 48,367,103 | 21,976,268.59 | 21,976,268.59 |
| 未分配利润 | 439,255,217.21 | 437,710,562.97 | 476,577,065.4 | 466,842,447.39 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,496,358,459.85 | 1,492,022,748.07 | 1,477,138,727.84 | 1,462,021,607.57 |
| 少数股东权益 | 27,788,895.03 | 27,369,263.9 | 25,282,198.13 | 23,498,949.42 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,524,147,354.88 | 1,519,392,011.97 | 1,502,420,925.97 | 1,485,520,556.99 |
| 负债和股东权益合计 | 2,307,326,846.86 | 2,305,515,184.73 | 2,303,464,207.37 | 2,091,839,035 |
| 公告日期 | 2025-04-24 | 2025-04-24 | 2024-10-29 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |